CYCLE PHARMACEUTICALS LAUNCHES NEW INFORMATIVE ONLINE MEETING SERIES FOR PATIENTS WITH TYROSINEMIA TYPE 1 IN THE US
Cycle Pharmaceuticals Launches New Informative Online Meeting Series For Patients With Tyrosinemia Type 1 In The Us Boston (MA), USA, April 13, 2020 – Cycle Pharmaceuticals (“Cycle”) is pleased to announce the launch of a new online meeting series for patients and their families with Hereditary Tyrosinemia Type 1 (HT-1) in the US. The meeting […]




